Renal Cell Carcinoma - Global Drugs Market Forecast and Pipeline Analysis to 2021

SKU ID : IGATE Research - 10963823

Publishing Date : 16-May-2016

No. of pages : 148

PRICE
1190
1600

  • Renal cell carcinoma is the most common type of kidney cancer in adults. It accounts for approximately 3% of adult malignancies and 90-95% of neoplasms arising from the kidney. The global renal cell carcinoma drugs market is anticipated to cross US$ 4.3 Billion mark by 2021. There are many factors, like smoking, hypertension, unhealthy eating habits and family history, which increase the risk of occurrence of renal cell carcinoma. The major driving factors for the renal cell carcinoma drugs market are increasing risk of lifestyle induced diseases, growing prevalence of renal cell carcinoma, increasing geriatric population base and quick diagnosis with modern imaging techniques.

    The major drugs used for the treatment of renal cell carcinoma include Sutent, Nexavar, Votrient, Avastin and Inyta amongst others. Sutent accounts for largest share of the global renal cell carcinoma drugs market in 2015, while, Votrient is projected to witness the strongest growth during the forecasting period. The most recent drugs approved for the treatment of renal cell carcinoma is Bristol-Myers Squibb’s Opdivo. Moreover, there are many pipeline drugs in various phases of clinical trials, which will fuel the growth of renal cell carcinoma drugs market.

    iGATE RESEARCH report entitled “Renal Cell Carcinoma - Global Drugs Market Forecast and Pipeline Analysis to 2021” provides a comprehensive analysis of the fast-evolving high growth renal cell carcinoma therapeutics market. This 148 Page report with 58 Figures and 4 Tables has been analyzed from 7 viewpoints:

    1. Renal Cell Carcinoma (RCC) - Disease Overview
    2. Renal Cell Carcinoma (RCC) - Epidemiology
    3. Global Renal Cell Carcinoma - Diagnosed Incident Cases to 2023 (8 Countries Covered)
    4. Global Renal Cell Carcinoma - Five-Year Diagnosed Prevalent Cases to 2023 (8 Countries Covered)
    5. Global Renal Cell Carcinoma - Major Branded Drugs Product Profiles and Sales Analysis to 2021 (11 Brands Covered)
    6. Global Renal Cell Carcinoma Drugs - Pipeline Analysis (18 Drugs Covered)
    7. Global Renal Cell Carcinoma Drugs – Market Drivers and Restraints

    Global Renal Cell Carcinoma - Diagnosed Incident Cases and Five-Year Diagnosed Prevalent Cases to 2023 (8 Countries Covered)

    1. United States
    2. Italy
    3. Germany
    4. France
    5. United Kingdom
    6. Spain
    7. Japan
    8. China

    Global Renal Cell Carcinoma - Major Branded Drugs Product Profiles and Sales Analysis to 2021 (11 Brands Covered)

    1. Sutent (Sunitinib)
    2. Nexavar (Sorafenib)
    3. Votrient (Pazopanib)
    4. Avastin (Bevacizumab)
    5. Afinitor (Everolimus)
    6. Inlyta (Axitinib)
    7. Torisel (Temsirolimus)
    8. Proleukin (Aldesleukin)
    9. Opdivo (Nivolumab) - Product Profile
    10. Tarceva (Erlotinib) - Product Profile
    11. Interferon-alfa - Product Profile

    Global Renal Cell Carcinoma Drugs - Pipeline Analysis (17 Companies Drugs Covered)

    1. Merck & Co., Inc.
    2. Exelixis Inc
    3. Argus Therapeutics, Inc.
    4. Bristol-Myers Squibb
    5. Genentech/Roche
    6. Immatics Biotechnologies
    7. AVEO Oncology
    8. Eisai
    9. Acceleron
    10. Rexahn Pharmaceuticals
    11. Bionomics
    12. Cerulean Pharma Inc
    13. Celldex Therapeutics
    14. TVAX Biomedical
    15. TRACON Pharmaceuticals
    16. Eli Lilly
    17. AstraZeneca


    Data Sources

    iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

    Research Methodologies

    Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

    Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports